X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (127) 127
hematology (76) 76
index medicus (63) 63
female (45) 45
male (44) 44
aged (39) 39
middle aged (38) 38
oncology (36) 36
leukemia, lymphocytic, chronic, b-cell - pathology (35) 35
leukemia, lymphocytic, chronic, b-cell - immunology (33) 33
animals (29) 29
leukemia, lymphocytic, chronic, b-cell - genetics (29) 29
adult (23) 23
expression (23) 23
apoptosis (22) 22
cd38 expression (21) 21
abridged index medicus (20) 20
leukemia, lymphocytic, chronic, b-cell - metabolism (20) 20
aged, 80 and over (19) 19
b-lymphocytes - immunology (19) 19
b-lymphocytes - pathology (19) 19
cancer (19) 19
leukemia (19) 19
mice (19) 19
chronic lymphocytic leukemia (18) 18
chronic lymphocytic-leukemia (18) 18
b-cells (17) 17
immunology (17) 17
hemic and lymphatic diseases (13) 13
activation (12) 12
cll (12) 12
antigen receptors (11) 11
disease progression (11) 11
signal transduction (11) 11
b-lymphocytes - metabolism (10) 10
bone marrow - pathology (10) 10
cells, cultured (10) 10
chemotherapy (10) 10
human necessities (10) 10
hygiene (10) 10
leukemia, lymphocytic, chronic, b-cell - drug therapy (10) 10
lymphomas (10) 10
medical or veterinary science (10) 10
preparations for medical, dental, or toilet purposes (10) 10
tumor cells, cultured (10) 10
autoimmunity (9) 9
lymphocyte activation (9) 9
multiple myeloma (9) 9
peptides (9) 9
prognosis (9) 9
t-cells (9) 9
disease (8) 8
genetics (8) 8
hematology, oncology and palliative medicine (8) 8
immunoglobulin heavy chains - genetics (8) 8
immunoglobulin variable region - genetics (8) 8
leukemia, lymphocytic, chronic, b-cell (8) 8
leukemia, lymphocytic, chronic, b-cell - etiology (8) 8
leukemia, lymphocytic, chronic, b-cell - therapy (8) 8
lymphoma (8) 8
medicine, research & experimental (8) 8
mice, transgenic (8) 8
microenvironment (8) 8
receptor (8) 8
rituximab (8) 8
survival (8) 8
therapy (8) 8
adolescent (7) 7
amino acid sequence (7) 7
angiogenesis (7) 7
antineoplastic agents - therapeutic use (7) 7
b cells (7) 7
bortezomib (7) 7
care and treatment (7) 7
cell biology (7) 7
chemistry (7) 7
flow cytometry (7) 7
gene (7) 7
immunoglobulins (7) 7
in-vitro (7) 7
leukemia, lymphocytic, chronic, b-cell - diagnosis (7) 7
lymphocytes (7) 7
medicine (7) 7
metallurgy (7) 7
molecular sequence data (7) 7
organic chemistry (7) 7
phosphorylation (7) 7
recurrence (7) 7
specific therapeutic activity of chemical compounds ormedicinal preparations (7) 7
t-lymphocytes - immunology (7) 7
tumor microenvironment (7) 7
zap-70 expression (7) 7
article (6) 6
b lymphocytes (6) 6
cell line (6) 6
cell line, tumor (6) 6
chronic lymphocytic leukaemia (6) 6
disease models, animal (6) 6
follow-up studies (6) 6
gene expression regulation, neoplastic (6) 6
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (231) 231
French (6) 6
German (6) 6
Spanish (4) 4
Italian (2) 2
Korean (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2005, Current topics in microbiology and immunology, ISBN 3540252797, Volume 294., vi, 189
Chronic lymphocytic leukaemia (CLL) is the most common leukaemia in the Western world. It is also the prototype of B-cell chronic lymphoid malignancies and of... 
Lymphocytic leukemia | Hematology | Cancer Research | Biomedicine
Book
Current topics in microbiology and immunology, ISBN 3540252797, Volume 298., vi, 189
Book
Annals of Oncology, ISSN 1569-8041, 03/2013, Volume 24, Issue 3, pp. 561 - 76
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9700, pp. 1512 - 1520
Summary Background Chemotherapy with high-dose methotrexate is the conventional approach to treat primary CNS lymphomas, but superiority of polychemotherapy... 
Internal Medicine | DEFERRED RADIOTHERAPY | MEDICINE, GENERAL & INTERNAL | B-CELL LYMPHOMA | INTERNATIONAL WORKSHOP | RESPONSE CRITERIA | EUROPEAN ORGANIZATION | CONSOLIDATING RADIOTHERAPY | NON-HODGKINS-LYMPHOMA | INITIAL TREATMENT | CENTRAL-NERVOUS-SYSTEM | CEREBROSPINAL-FLUID | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Lymphoma, Non-Hodgkin - radiotherapy | Cranial Irradiation - methods | Central Nervous System Neoplasms - radiotherapy | Adult | Lymphoma, Non-Hodgkin - drug therapy | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | Combined Modality Therapy | Remission Induction | Methotrexate - adverse effects | Antimetabolites, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Aged | Lymphoma, Non-Hodgkin - mortality | Central Nervous System Neoplasms - drug therapy | Central Nervous System Neoplasms - mortality | Cytarabine | Patient outcomes | Central nervous system diseases | Dosage and administration | Lymphomas | Drug therapy, Combination | Methotrexate | Drug therapy | Data analysis | Disease | Monoclonal antibodies | Data collection | Radiation therapy | Patients | Tropical diseases | Index Medicus | Abridged Index Medicus
Journal Article
1997, Chemical immunology, ISBN 9783805564601, Volume 67., x, 137
B cells used to be considered as a homogeneous population of cells destined to produce antibodies of increasing affinity and to maintain an immunological... 
Book
The New England Journal of Medicine, ISSN 0028-4793, 07/2014, Volume 371, Issue 3, pp. 213 - 223
Journal Article